CD123-targeted radiotheranostics of Acute Myeloid Leukemia with 89Zr/177Lu-labeled pivekimab
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-5052
Abstract: Introduction CD123, the interleukin-3 receptor alpha chain, is highly-expressed on AML blasts and stem cells but less on normal counterparts, making it an attractive target for targeted therapy. Pivekimab sunirine (IMGN632) is an antibody–drug conjugate… read more here.
Keywords: dfo pive; 177lu dtpa; 89zr dfo; cd123 ... See more keywords